CTO Nikolaj Skak and Industrial Postdoc Nina Mertz attended the AAPSComms PharmSci 360 October 22-25, 2023, in Orlando, FL.
It was great to see that drug-device combination products were a well-represented topic at the conference and discussed at several sessions and keynote speeches. It made it all the more exciting to add to the discussions with our poster and a Rapid Fire talk on the BIONDD™ technology for oral delivery of biologics.
On February 27th 2024, Karsten Lindhardt CEO and founder of Biograil had the pleasure of presenting the BIONDD™ technology to an exclusive audience at the CEO & Investor Conference in NYC.
Take a look at the technology at Biograil™ – Welcome to Biograil
I am happy to share that, I have finalized my project “Assessment of barriers towards oral treatment of autoimmune diseases with adalimumab” by presenting my research to colleagues at Biograil™, last week, March 7th, 2024.
The project was part of my education at Syddansk Universitet – University of Southern Denmark, where I got the opportunity to combine a disease related ailment with potential pharmaceutical treatment.
The project represents the potential of innovative treatment with BIONDD™ in patients suffering from Crohn’s disease.
The project was conducted in collaboration with Biograil™ and Syddansk Universitet – University of Southern Denmark. A special thank you to my supervisors Nina Mertz and Søren Fisker Schmidt, who believed in this project from the beginning.